GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » EV-to-FCF

TalkMed Group (SGX:5G3) EV-to-FCF : 35.66 (As of Apr. 05, 2025)


View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TalkMed Group's Enterprise Value is S$510.40 Mil. TalkMed Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was S$14.32 Mil. Therefore, TalkMed Group's EV-to-FCF for today is 35.66.

The historical rank and industry rank for TalkMed Group's EV-to-FCF or its related term are showing as below:

SGX:5G3' s EV-to-FCF Range Over the Past 10 Years
Min: 12.34   Med: 19.81   Max: 36.85
Current: 35.66

During the past 13 years, the highest EV-to-FCF of TalkMed Group was 36.85. The lowest was 12.34. And the median was 19.81.

SGX:5G3's EV-to-FCF is ranked worse than
73.42% of 395 companies
in the Healthcare Providers & Services industry
Industry Median: 16.99 vs SGX:5G3: 35.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-05), TalkMed Group's stock price is S$0.445. TalkMed Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was S$0.032. Therefore, TalkMed Group's PE Ratio (TTM) for today is 13.91.


TalkMed Group EV-to-FCF Historical Data

The historical data trend for TalkMed Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group EV-to-FCF Chart

TalkMed Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.03 19.61 13.67 21.26 35.62

TalkMed Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.67 - 21.26 - 35.62

Competitive Comparison of TalkMed Group's EV-to-FCF

For the Medical Care Facilities subindustry, TalkMed Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TalkMed Group's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where TalkMed Group's EV-to-FCF falls into.


;
;

TalkMed Group EV-to-FCF Calculation

TalkMed Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=510.402/14.315
=35.66

TalkMed Group's current Enterprise Value is S$510.40 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TalkMed Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was S$14.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TalkMed Group  (SGX:5G3) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

TalkMed Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.445/0.032
=13.91

TalkMed Group's share price for today is S$0.445.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TalkMed Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was S$0.032.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


TalkMed Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of TalkMed Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


TalkMed Group Business Description

Traded in Other Exchanges
N/A
Address
3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group Headlines

No Headlines